Article info

Download PDFPDF
Original research
Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma

Authors

  1. Correspondence to Dr Shumei Song, Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; ssong{at}mdanderson.org; Dr Jaffer A Ajani, Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA; jajani{at}mdanderson.org
View Full Text

Citation

Song S, Chen Q, Li Y, et al
Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma

Publication history

  • Received March 20, 2020
  • Revised January 3, 2021
  • Accepted January 5, 2021
  • First published January 24, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.